MedPath

Effect of Zinc and Folic Acid on semen analysis and sperm functio

Phase 2
Conditions
Male Infertility.
Male infertility
Registration Number
IRCT138706091079N2
Lead Sponsor
Academic Center for Education and Culture and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
100
Inclusion Criteria

inclusion criteria:infertile men with oligoasthenoteratozoospermia, 20-45 years old

exclusion criteria: men with severe and chronic underlaying disease such as dibet, SC disabilities.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sperm function test. Timepoint: before treatment commence and 16 weeks after treatment. Method of measurement: sperm function tests according to WHO standard.;Semen analysis. Timepoint: before treatment commence and 16 weeks after treatment. Method of measurement: routine semen analysis according to WHO standard.
Secondary Outcome Measures
NameTimeMethod
Total antioxidant capacity (TAC). Timepoint: 16 weeks after treatment. Method of measurement: spectrophotometry.;Reactive oxygen species (ROS). Timepoint: 16 weeks after treatment. Method of measurement: chemiluminescence.
© Copyright 2025. All Rights Reserved by MedPath